BusinessVBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901By Nasdaq OMXJan 17, 2018, 1:00 PM UTC
BusinessRadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumorsBy Nasdaq OMXJan 10, 2018, 10:00 AM UTC
BusinessActinium Pharmaceuticals to Present at Biotech Showcase™ 2018 and Participate in Partnering SessionsBy Nasdaq OMXJan 3, 2018, 12:30 PM UTC
BusinessActinium Pharmaceuticals Provides Update on Pivotal Phase 3 Trial of Iomab-B: Independent Data Monitoring Committee Recommends SIERRA Trial ContinueBy Nasdaq OMXDec 27, 2017, 2:00 PM UTC
BusinessAchillion Initiates Phase I First-In Study of ACH-5228, a Next-Generation Oral Small Molecule Inhibitor of Complement Factor DBy Nasdaq OMXDec 20, 2017, 11:05 AM UTC
BusinessAsklepion Pharmaceuticals Announces Special Protocol Assessment (SPA) Agreement with FDA for Phase 3 Program of Intravenous CitrullineBy Nasdaq OMXDec 19, 2017, 2:01 PM UTC
BusinessVBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B VaccineBy Nasdaq OMXDec 19, 2017, 1:00 PM UTC
